Jane Street
CDIO icon

Jane Street’s Cardio Diagnostics CDIO Stock Holding History

Jane Street’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$159K Buy
+81,283
New +$213K ﹤0.01% 10343
2025
Q2 		– Sell
-2,694
Closed -$26.7K – 9726
2025
Q1 		$26.7K Sell
2,694
-1,058
-28% -$16.5K ﹤0.01% 9110
2024
Q4 		$103K Buy
+3,752
New +$52K ﹤0.01% 8752

Other funds holding CDIO

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Jane Street's CDIO Position: Q1 2026 in Review

Jane Street opened a new position in Cardio Diagnostics (CDIO) in Q1 2026: 81,283 shares worth $159K. The stake represents ﹤0.01% of the portfolio and ranks #10343 among its holdings. This is a return to the name: Jane Street previously reported a position in CDIO as recently as Q1 2025.

Jane Street first reported a position in CDIO in Q4 2024 and has held it in 3 quarters since. 16 funds tracked by Wall St. Rank hold CDIO as of Q1 2026.

  • Jane Street held 81,283 shares of Cardio Diagnostics worth $159K as of Q1 2026.
  • Cardio Diagnostics was a new Jane Street position in Q1 2026.
  • Cardio Diagnostics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10343 holding.
  • Jane Street first reported a position in Cardio Diagnostics in Q4 2024 and has held it in 3 quarters since.
  • 16 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.